Article Details
Retrieved on: 2018-01-08 08:33:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Vanguard Group</b> Inc. raised its stake in shares of Revance Therapeutics by 7.3% during the 2nd quarter. <b>Vanguard Group</b> Inc. now owns 931,623 shares of the biopharmaceutical company's stock worth $24,595,000 after purchasing an additional 63,505 shares in the last quarter. Finally, QS Investors ...</div>
Article found on:
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here